Risofos 35 Mg Aronex Life Sciences
Information About Risofos 35 Mg Aronex Life Sciences
About Risofos 35 Mg Aronex Life Sciences
Medicine Brand Risofos 35 mg Aronex Life Sciences is manufactured by Aronex Life Sciences Pvt Ltd and mainly contents the generic drug Risedronate.
Pakaging
4 Tablet
Active Ingredients For Risofos 35 Mg Aronex Life Sciences
Risedronate 35 mg
Diseases List For Which Risofos 35 Mg Aronex Life Sciences Is Prescribed
This Drug Is Prescribed For Pagets disease of bone Treatment and prophylaxis of postmenopausal or corticosteroidinduced osteoporosis
Other Significations For Risofos 35 Mg Aronex Life Sciences
This Medication Risedronate is in a class of drugs called bisphosphonates used for the treatment of Pagets disease of bone in which the formation of bone is abnormal and in persons with osteoporosis in which the density and strength of bones are reduced Other biphosphonates include the drugs alendronate Fosamax ibandronate Boniva pamidronate Aredia tiludronate Skelid and etidronate Didronel Bone is continually being formed and dissolved New bone is laid down by cells called osteoblasts while old bone is removed by cells called osteoclasts Bisphosphonates strengthen bone by inhibiting bone removal resorption by osteoclasts By slowing down the rate at which bone is dissolved risedronate increases the amount of bone Risedronate is more potent in blocking the dissolution of bone than etidronate and alendronate The FDA approved risedronate for the treatment of Pagets disease in 1998 and for the prevention and treatment of osteoporosis in 1999
Precautions To Be Taken Before Risofos 35 Mg Aronex Life Sciences
Food Calcium Antacids And Medications Containing Iron Magnesium Or Aluminum Reduce The Absorption Of Risedronate Resulting In Loss Of Effectiveness Thus It Should Be Taken With Plain Water Only
Major Conditions And Care
Pregnancy And Risofos 35 Mg Aronex Life Sciences
Can We Take Risofos 35 Mg Aronex Life Sciences During Pregnancy?
Pregnancy Class : D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans but potential benefits may warrant use of the drug in pregnant women despite potential risks
Lactation And Risofos 35 Mg Aronex Life Sciences
Can We Use Risofos 35 Mg Aronex Life Sciences During Lactation
Lactation Class L4 There is positive evidence of risk to a breastfed infant or to breastmilk production but the benefits of use in breastfeeding mothers may be acceptable despite the risk to the infant eg if the drug is needed in a lifethreatening situation or for a serious disease for which safer drugs cannot be used or are ineffective
Side Effects Of Risofos 35 Mg Aronex Life Sciences
Nausea stomach upset skin rash acute toxicity